|
Research Management and Support
|
RMS2008
|
$336,082,664
|
$4,688,100
|
N/A
|
National Cancer Institute
|
|
p53 - Regulators and Effectors
|
5P01CA080058-09
|
$1,348,536
|
$471,988
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
SBIR Topic 246- Integrating Patient-Reported Outcomes in Hospice and Palliative C
|
N43CO800051-000
|
$149,999
|
$149,999
|
ABIDI, SYED
|
DYNAMIC CLINICAL SYSTEMS INC:1120447
|
|
Web-based Family History Screening for Hereditary Breast Cancer Risk
|
5R21CA127837-02
|
$154,500
|
$154,500
|
ACHESON, LOUISE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-10
|
$633,099
|
$221,585
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
Radioactive Nanoparticle Immunoconjugates for the Treatment of Solid Tumors
|
5R21CA128421-02
|
$171,000
|
$171,000
|
ADAMS, GREGORY
|
FOX CHASE CANCER CENTER
|
|
HOWARD UNIVERSITY CANCER CENTER/JOHNS HOPKINS CANCER CENTER PARTNERSHIP
|
5U54CA091431-08
|
$1,535,549
|
$767,775
|
ADAMS-CAMPBELL, LUCILE
|
HOWARD UNIVERSITY
|
|
MMC and VICC: Partners in Eliminating Cancer Disparities
|
5U54CA091408-08
|
$1,710,826
|
$684,330
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
SHP2-Mediated Synergy Between EGFR/HER2 and Beta Catenin in Breast Oncogenesis
|
5R01CA124940-02
|
$250,515
|
$250,515
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Genomewide association in early-onset breast cancer
|
5U01CA122171-03
|
$1,170,110
|
$1,170,110
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-05
|
$234,166
|
$100,691
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
"Genetic interactions between Tgfb1 and Skts15/Tgfbm3 in cancer"
|
5R01CA116019-02
|
$296,906
|
$148,453
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Epidemiologic Studies of Techa River Cohorts
|
N01CP045505-000
|
$105,573
|
$10,557
|
AKLEYEV, ALEXANDER
|
Urals Research Center for Radiation Mede
|
|
Training Program in Cancer Biology
|
5T32CA079448-09
|
$491,121
|
$245,561
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
|
5R01CA120552-02
|
$86,515
|
$86,515
|
AKPORIAYE, EMMANUEL
|
UNIVERSITY OF ARIZONA
|
|
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
|
7R01CA120552-03
|
$171,695
|
$171,695
|
AKPORIAYE, EMMANUEL
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
|
Using Markov Decision Processes to Optimize Breast Biopsy Decision Making
|
1R21CA129393-01A1
|
$185,293
|
$185,293
|
Alagoz, Oguzhan
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Using the UWBCS to Assess Racial Disparities in Breast Cancer Incidence & Surviva
|
5R03CA130727-02
|
$69,740
|
$69,740
|
Alagoz, Oguzhan
|
UNIVERSITY OF WISCONSIN MADISON
|
|
A Novel Regulator of Cancer Cell Migration and Invasion
|
5R01CA115706-03
|
$215,746
|
$215,746
|
ALAHARI, SURESH
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
SBIR TOPIC 236 PHASE 1 ANTIBODY ARRAY FOR CANCER DETECTION
|
N43CN800021-000
|
$149,995
|
$50,998
|
ALAM, MAKSUDUL
|
INNOSENSE, LLC
|
|
Prospective study of farmers and their families (Agricultural health study)
|
Z01 CP010119-02020
|
$1,233,935
|
$61,697
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Clinical Academic Oncologist Training Program
|
5K12CA087718-09
|
$446,225
|
$89,245
|
Albertini, Mark
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S5
|
$3,963,721
|
$356,735
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S6
|
$100,000
|
$9,000
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Cancer Prevention and Control Training Grant
|
5R25CA078447-09
|
$511,052
|
$51,105
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
CNP for Older Underserved African American Adults
|
3U01CA114583-04S1
|
$83,552
|
$20,888
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Detroit CNP: "Social Network Analysis for CNP Partnerships"
|
3U01CA114583-04S2A1
|
$75,250
|
$18,813
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CNP for Older Underserved African American Adults
|
5U01CA114583-04
|
$473,207
|
$118,302
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
CANCER INFORMATION SERVICE
|
N02CO511003-005
|
$630,200
|
$166,373
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Understanding Decision-Making in Breast Cancer Reconstruction
|
1R21CA122467-01A2
|
$83,575
|
$83,575
|
ALDERMAN, AMY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The Role of Syndecan-1 in Mouse Mammary Neoplasia
|
2R01CA090877-06A2
|
$295,173
|
$295,173
|
ALEXANDER, CAROLINE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Novel Targeted Therapeutics for Cental Nervous System Malignancies
|
5R01CA112519-03
|
$327,069
|
$163,535
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Breast vibroacoustography with array probe
|
5R21CA121579-02
|
$339,167
|
$339,167
|
Alizad, Azra
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Neighborhood Characteristics Related to Cancer Risk Factors and Outcomes
|
1R21CA127777-01A1
|
$179,968
|
$59,389
|
ALLISON, MATTHEW
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Molecular targeting of the survivin pathway in cancer
|
5R01CA090917-09
|
$288,775
|
$14,439
|
Altieri, Dario
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Antioxidant supplements, genetics and chemotherapy outcomes
|
5R01CA116395-03
|
$574,954
|
$574,954
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Race & Risk Factors for Early/Aggressive Breast Cancer
|
7R01CA100598-05
|
$684,259
|
$684,259
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
Z01 BC 010887
|
$168,191
|
$168,192
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
Z01 BC 010030
|
$863,565
|
$215,891
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
NANOTHERAPEUTIC STRATEGY FOR MULTIDRUG RESISTANT TUMORS
|
5R01CA119617-04
|
$362,876
|
$181,438
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Contributions of sleep/rhythms/fatigue to chemobrain
|
5R01CA112035-04
|
$396,409
|
$396,409
|
Ancoli-Israel, Sonia
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Biobehavioral Responses to Cancer
|
5K05CA098133-05
|
$146,427
|
$146,427
|
ANDERSEN, BARBARA
|
OHIO STATE UNIVERSITY
|
|
Phosphatidylinositol (PI) Signaling Role in Ephitelial / Mesenchymal Transition
|
5R01CA104708-05
|
$282,819
|
$70,705
|
ANDERSON, RICHARD
|
UNIVERSITY OF WISCONSIN MADISON
|
|
MAMMARY GLAND BIOLOGY GRC
|
5R13CA128408-02
|
$8,000
|
$8,000
|
ANDERSON, STEVEN
|
GORDON RESEARCH CONFERENCES
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
Z01 CP010183-00560
|
$4,450
|
$222
|
Anderson, William
|
DCEG (NCI)
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$8,965
|
Anderson, William
|
DCEG (NCI)
|
|
Swedish CER occupational study
|
Z01 CP010183-02050
|
$10,053
|
$2,011
|
Anderson, William
|
DCEG (NCI)
|
|
SEER Special Studies
|
Z01 CP010183-10316
|
$62,934
|
$37,761
|
Anderson, William
|
DCEG (NCI)
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-14
|
$712,896
|
$712,896
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
Psychological and Behavioral Impact of Cancer Screening
|
5K05CA096558-05
|
$128,411
|
$102,729
|
Andrykowski, Michael
|
UNIVERSITY OF KENTUCKY
|
Total relevant funding to Breast Cancer for this search: $572,597,443
|